About
Dr. Sudip Shrestha
Dr. Sudip Shrestha is the present Executive Chairman of Nepal Cancer Hospital and Research Center, recognized as the best medical oncologist in Kathmandu. His remarkable journey in the medical field began in 1985 AD when he commenced his MBBS from Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), University of Madras, India. Over the years, Dr. Shrestha has gathered immense experience and respect in oncology. He played a pivotal role in the establishment of Bhaktapur Cancer Hospital (2nd cancer hospital in Nepal) and has continued his dedicated service to this day. Currently, as the Executive Chairman of Nepal Cancer Hospital and Research Center, he is working tirelessly to bring state-of-the-art technology for treating cancer all under one roof. Dr. Sudip Shrestha is widely acknowledged as the best medical oncologist in Nepal, thanks to his unwavering commitment to advancing cancer treatment. His expertise and dedication have also earned him the reputation of being the best cancer specialist in Nepal. Under his leadership, Nepal Cancer Hospital and Research Center has become a beacon of hope for cancer patients, providing comprehensive and advanced care. As the best cancer doctor in Nepal, Dr. Shrestha’s vision is to make cutting-edge cancer treatment accessible to all. His efforts have significantly improved the standard of oncology care in the country, making him a respected figure in the medical community.
Education
MBBS
MBBS from Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), University of Madras, India
MD in Internal Medicine
MD in Internal Medicine (First Class) from Tribhuvan University, Kathmandu, Nepal.
Post Graduate in Medical Oncology
Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India
Contributions
Dr. Sudip Shrestha has tirelessly put efforts in improving the life of cancer
patients in the country.
Honours
&
Awards
Some of the few achievements of Dr. Sudip’s renowned career
Presidential award by President of Nepal 2019 for his unparalleled contributions in the field of cancer
Awarded Fellowship by Royal College of Physician Edinburgh (FRCP) for his contributions in cancer in Nepal
Sixth Kobayashi foundation award, JAPAN, 2022. Given to the 2 oncologist from the Asian countries for their contribution in cancer in his motherland
Awarded as the Winner of Young Investigator Award (YIA) on 9th International Conference of Asian oncology Society held In Gifu city, Japan
• Presidential award by President of Nepal 2019 for his unparalleled contributions in the field of cancer
• Sixth Kobayashi foundation award, JAPAN, 2022. Given to the 2 oncologist from the Asian countries for their contribution in cancer in his motherland.
• Awarded Fellowship by Royal College of Physician Edinburgh (FRCP) for his contributions in cancer in Nepal.
• Best free paper award on 4th International conference of International college of surgeons- Nepal section. 2004, Kathmandu.
• Awarded as a best contributor as a cancer specialist in the country in the year 2004 ( Nepal Cancer Relief Society).
• Winner of Young investigational Award (YIA) on 9th International Conference of Asian oncology Society hold In Gifu city, Japan.
• Nominated By ASCO as a a member of ASCO expert panel charged with the development of a Resource Stratified Guideline on Palliative Care in Global Settings.
• Awarded as Pharma Leaders Iconic Global Healthcare Leader of the Year 2022 by Pharma Leaders Network 7 Media Group, India for his outstanding contributions in the field of oncology in Nepal.
Professional Memberships
& Affiliations
- Member Technical working committee for National Cervical Cancer Screening and prevention implementation plan 1916-20.
- Member of an expert panel charged with the development of a Resource Stratified Guideline on Palliative Care in Global Settings: ASCO; in the year 2016.
- Council member from Nepal ACOS (Asian Clinical oncology society)
- Executive member and Scientific committee Chairman SAARC Federation of Oncology- Nepal Chapter (SFO-N): for 2012-2016.
- Vice treasurer Om health foundation, Nepal Adviser, Richa Bajimaya Memorial foundation.
- Treasurer Nepal Breast cancer support group.
- Served as president for NAPCare from 2012- 2014.
- Founder President and Vice president Nepalese Palliative care group (NAPCare 2009)
- President Nepal Cancer support group (NCSG 2009)
- Executive member of Society of Internal Medicine of Nepal (SIMON) from 2002 to 2004 and 2005 to 2007, 2007 to 2009.
- Founder member of Om Health Foundation, Kathmandu, Nepal, a Voluntary organization to help poor patients.
- Rotarian “ Rotary club of Yala” District, Nepal
- Honorary Member of Patan Jaycees (Voluntary Organization)
- Life member of Nepal Oncology society (NEONS).
- Life member of SAARC Federation of Oncology, Nepal.
- Medicine of Nepal (SIMON)
- Life member of Society of Internal
- Life Member of Nepal Medical Association
- Medical Council of Nepal.
- Medical Council of Tamil Nadu, India.
Publications
- Capecitabine: Single institution experience from North India in metastatic breast cancer. Journal of Clinical Oncology 22(14_suppl):815-815 · July 2004. ( https://ascopubs.org/doi/abs/10.1200/jco.2004.22.90140.815 )
- “Carcinoma Gall Bladder : An Institutional Experience.” JNMA; journal of the Nepal Medical Association 45(164):342-6 · October 2006. (https://www.ncbi.nlm.nih.gov/pubmed/17676069).
- “Palliative Care Development: The Nepal Model”, Journal of Pain and Symptom Management, Vol. 33 No. 5 May 2007. (https://www.jpsmjournal.com/article/S0885-3924(07)00111-X/pdf )
- Deep Seated thoracic and abdominal lesions usefulness of ultrasound guided fine needle aspiration cytology, a 3 yr experience.” J Nep Med Assoc March 2010. (https://pdfs.semanticscholar.org/a045/e96716a44a1cba912a8584fe433382309c65.pdf
- Published article as an expert commentary : “Challenges and Solutions for Developing Palliative Care in Nepal;” Palliative Care in Oncology Symposium Daily News Archive, October 9, 2015. ASCO. (http://pallonc.org/challenges-and-solutions-developing-palliative-care-nepal)
- “Epidemiology and clinical profile of breast cancer in central Nepal” : poster presentation on 3rd World Congress on Women’s Health and Breast Cancer” , October 03-05, 2016 London, UK.
- “Problems of Breast Cancer Survivors Living in an Urban Area of Nepal” Asia‐Paci c Journal of Oncology Nursing • Jul‐Sep 2016 • Vol 3 • Issue 3 http://www.apjon.org/article.asp?issn=2347-5625;year=2016;volume=3;issue=3;spage=289;epage=296;aulast=Sapkota;type=0 )
- Epidemiology and Clinical Profile of Breast Cancer in Central Nepal, Annals of Breast Cancer Research: Ann Breast Cancer Res 1(1): 1005 (https://pdfs.semanticscholar.org/f41b/80dd8bdb2f98f7cd3ee4b2b302afeddbe754.pdf )
- Social support, quality of life and mental health status in breast cancer patients: Research Article: Cancer Rep Rev, 2017 (https://www.oatext.com/pdf/CRR-1-107.pdf )
- “Macula Erythematous Rash Due to Temozolomide Involving Head and Neck Region Only” March 2018 (https://symbiosisonlinepublishing.com/pharmacovigilance/pharmacovigilance21.php )
- “Adverse Drug Reaction due to Cancer Chemotherapy and its Financial Burden in Different Hospitals of Nepal:” International journal of Pharmacovigilance; (http://dx.doi.org/10.15226/2476-2431/2/1/00114) Published: April 18, 2017
- “Can clinical pharmacists bridge a gap between medical oncologists and patients in resource-limited oncology settings? An experience in Nepal” (Journal of Oncology Pharmacy Practice 25(3):765–768 · June 2018 ( https://doi.org/10.1177/1078155218784734 )
- “Establishment of the first cancer hospital-based pharmacovigilance center in Nepal” Research in Social and Administrative Pharmacy 14(11) · July 2018. ( https://doi.org/10.1016/j.sapharm.2018.07.017)
- 09-09 “Prevalence of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Carcinoma Lungs at a Cancer Center in Nepal” Journal of Thoracic Oncology 13(10):S950-S951 · October 2018. (https://doi.org/10.1016/j.jtho.2018.08.1778)
- “Establishment of the hemovigilance system in an oncology-based hospital of Nepal: A new starting in the field of blood transfusion in limited resource settings.” (https://www.researchgate.net/publication/330124674_Establishment_of_the_hemovigilance_system_in_an_oncology-based_hospital_of_Nepal_A_new_starting_in_the_field_of_blood_transfusion_in_limited_resource_settings.) Dec 2018. (DOI: 10.2478/medu-2018-0008)
- “ASCO Guideline report: Palliative Care in the Global Setting—ASCO Resource-Stratified Practice Guideline.” Journal of Clinical Oncology 36(34_suppl):85-85 · December 2018. (https://www.researchgate.net/publication/330124674_Establishment_of_the_hemovigilance_system_in_an_oncology-based_hospital_of_Nepal_A_new_starting_in_the_field_of_blood_transfusion_in_limited_resource_settings )
- “Establishment and Achievements of Drug and Therapeutic Committee at the Oncology-Based Hospital of Nepal.” INDIAN JOURNAL OF PHARMACY PRACTICE 12(1):41-44 · February 2019 (https://ijopp.org/sites/default/files/InJPharPract-12-1-41.pdf )
- Polypharmacy in elderly cancer patients cancer patients Professional Qualification: Review article (researchgate.net/publication/331093128) March 2019 (DOI: 10.1002/agm2.12051 )
- “Workshop on proposal writing on research for health care professionals: a brief report”: Journal of Multidisciplinary Healthcare. Volume 12:565-572 · July 2019.(https://www.researchgate.net/publication/331093128_Polypharmacy_in_elderly_cancer_patients_Challenges_and_the_way_clinical_pharmacists_can_contribute_in_resource-limited_settings ) (DOI: 10.2147/JMDH.S211257 )
- A survey of cancer care institutions in Nepal to inform design of a pain management mobile application. (https://acrobat.adobe.com/id/urn:aaid:sc:AP:85a852a7-7061-42b7-b5c1-c02c654e5f9e?viewer%21megaVerb=group-discover)
- “Performance of Distress Thermometer: A Study among Cancer.” J Nepal Health Res Counc 2023 July-Sept;21(60):472-78
(http://jnhrc.com.np/index.php/jnhrc/article/view/4719/1500) - “Study to evaluate awareness about medication errors and impact of an educational intervention among healthcare personnel in a cancer hospital.” Journal of Oncology Pharmacy Practice . First published online February 25, 2024(https://journals.sagepub.com/doi/abs/10.1177/10781552241235898)
